636 related articles for article (PubMed ID: 19180486)
1. Increased expression of CD40 on bone marrow CD34+ hematopoietic progenitor cells in patients with systemic lupus erythematosus: contribution to Fas-mediated apoptosis.
Pyrovolaki K; Mavroudi I; Sidiropoulos P; Eliopoulos AG; Boumpas DT; Papadaki HA
Arthritis Rheum; 2009 Feb; 60(2):543-52. PubMed ID: 19180486
[TBL] [Abstract][Full Text] [Related]
2. The CD40/CD40 ligand interactions exert pleiotropic effects on bone marrow granulopoiesis.
Mavroudi I; Papadaki V; Pyrovolaki K; Katonis P; Eliopoulos AG; Papadaki HA
J Leukoc Biol; 2011 May; 89(5):771-83. PubMed ID: 21367977
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of interleukin-1beta-converting enzyme in human hematopoietic progenitor cells results in blockade of cytokine-mediated apoptosis and expansion of their proliferative potential.
Sloand EM; Young NS; Sato T; Kim S; Maciejewski JP
Exp Hematol; 1998 Oct; 26(11):1093-9. PubMed ID: 9766451
[TBL] [Abstract][Full Text] [Related]
4. Normal bone marrow hematopoietic stem cell reserves and normal stromal cell function support the use of autologous stem cell transplantation in patients with multiple sclerosis.
Papadaki HA; Tsagournisakis M; Mastorodemos V; Pontikoglou C; Damianaki A; Pyrovolaki K; Stamatopoulos K; Fassas A; Plaitakis A; Eliopoulos GD
Bone Marrow Transplant; 2005 Dec; 36(12):1053-63. PubMed ID: 16205726
[TBL] [Abstract][Full Text] [Related]
5. Human CD34+ hematopoietic stem/progenitor cells express high levels of FLIP and are resistant to Fas-mediated apoptosis.
Kim H; Whartenby KA; Georgantas RW; Wingard J; Civin CI
Stem Cells; 2002; 20(2):174-82. PubMed ID: 11897874
[TBL] [Abstract][Full Text] [Related]
6. Abnormal Fas/FasL and caspase-3-mediated apoptotic signaling pathways of T lymphocyte subset in patients with systemic lupus erythematosus.
Xue C; Lan-Lan W; Bei C; Jie C; Wei-Hua F
Cell Immunol; 2006 Feb; 239(2):121-8. PubMed ID: 16808908
[TBL] [Abstract][Full Text] [Related]
7. Quantitative analysis of Fas and bcl-2 expression in hematopoietic precursors.
Maurillo L; Del Poeta G; Venditti A; Buccisano F; Battaglia A; Santinelli S; Caravita T; Epiceno AM; Del Moro B; Tamburini A; Picardi A; Suppo G; Catalano G; Bruno A; Amadori S
Haematologica; 2001 Mar; 86(3):237-43. PubMed ID: 11255269
[TBL] [Abstract][Full Text] [Related]
8. Serum DNase I, soluble Fas/FasL levels and cell surface Fas expression in patients with SLE: a possible explanation for the lack of efficacy of hrDNase I treatment.
Tinazzi E; Puccetti A; Gerli R; Rigo A; Migliorini P; Simeoni S; Beri R; Dolcino M; Martinelli N; Corrocher R; Lunardi C
Int Immunol; 2009 Mar; 21(3):237-43. PubMed ID: 19181929
[TBL] [Abstract][Full Text] [Related]
9. The abnormal apoptosis of T cell subsets and possible involvement of IL-10 in systemic lupus erythematosus.
Wang H; Xu J; Ji X; Yang X; Sun K; Liu X; Shen Y
Cell Immunol; 2005 Jun; 235(2):117-21. PubMed ID: 16226734
[TBL] [Abstract][Full Text] [Related]
10. Reduced number and impaired function of circulating progenitor cells in patients with systemic lupus erythematosus.
Moonen JR; de Leeuw K; van Seijen XJ; Kallenberg CG; van Luyn MJ; Bijl M; Harmsen MC
Arthritis Res Ther; 2007; 9(4):R84. PubMed ID: 17764548
[TBL] [Abstract][Full Text] [Related]
11. GATA-1 transcription factor is up-regulated in bone marrow hematopoietic progenitor CD34(+) and erythroid CD71(+) cells in myelodysplastic syndromes.
Maratheftis CI; Bolaraki PE; Voulgarelis M
Am J Hematol; 2007 Oct; 82(10):887-92. PubMed ID: 17570514
[TBL] [Abstract][Full Text] [Related]
12. Aberrant expression of the costimulatory molecule CD40 ligand on monocytes from patients with systemic lupus erythematosus.
Katsiari CG; Liossis SN; Souliotis VL; Dimopoulos AM; Manoussakis MN; Sfikakis PP
Clin Immunol; 2002 Apr; 103(1):54-62. PubMed ID: 11987985
[TBL] [Abstract][Full Text] [Related]
13. Enhanced propensity of T lymphocytes in patients with systemic lupus erythematosus to apoptosis in the presence of tumour necrosis factor alpha.
Habib HM; Taher TE; Isenberg DA; Mageed RA
Scand J Rheumatol; 2009; 38(2):112-20. PubMed ID: 19110660
[TBL] [Abstract][Full Text] [Related]
14. Increased Fas and Bcl-2 expression on peripheral mononuclear cells from patients with active juvenile-onset systemic lupus erythematosus.
Liphaus BL; Kiss MH; Carrasco S; Goldenstein-Schainberg C
J Rheumatol; 2007 Jul; 34(7):1580-4. PubMed ID: 17516614
[TBL] [Abstract][Full Text] [Related]
15. Increased apoptosis of bone marrow CD34(+) cells and impaired function of bone marrow stromal cells in patients with systemic lupus erythematosus.
Papadaki HA; Boumpas DT; Gibson FM; Jayne DR; Axford JS; Gordon-Smith EC; Marsh JC; Eliopoulos GD
Br J Haematol; 2001 Oct; 115(1):167-74. PubMed ID: 11722430
[TBL] [Abstract][Full Text] [Related]
16. Effect of graft-versus-host disease (GVHD) on host hematopoietic progenitor cells is mediated by Fas-Fas ligand interactions but this does not explain the effect of GVHD on donor cells.
Iwasaki T; Hamano T; Saheki K; Kuroiwa T; Kataoka Y; Takemoto Y; Ogata A; Sugihara A; Terada N; Fujimoto J; Kakishita E
Cell Immunol; 1999 Oct; 197(1):30-8. PubMed ID: 10555993
[TBL] [Abstract][Full Text] [Related]
17. Effects of cyclosporine on hematopoietic and immune functions in patients with hypoplastic myelodysplasia: in vitro and in vivo studies.
Selleri C; Maciejewski JP; Catalano L; Ricci P; Andretta C; Luciano L; Rotoli B
Cancer; 2002 Nov; 95(9):1911-22. PubMed ID: 12404285
[TBL] [Abstract][Full Text] [Related]
18. Increased apoptosis in aplastic anemia bone marrow progenitor cells: possible pathophysiologic significance.
Philpott NJ; Scopes J; Marsh JC; Gordon-Smith EC; Gibson FM
Exp Hematol; 1995 Dec; 23(14):1642-8. PubMed ID: 8542959
[TBL] [Abstract][Full Text] [Related]
19. Evidence for downregulation of erythropoietin receptor in bone marrow erythroid cells of patients with chronic idiopathic neutropenia.
Pontikoglou C; Liapakis G; Pyrovolaki K; Papadakis M; Bux J; Eliopoulos GD; Papadaki HA
Exp Hematol; 2006 Oct; 34(10):1312-22. PubMed ID: 16982324
[TBL] [Abstract][Full Text] [Related]
20. The relative extent and propensity of CD34+ vs. CD34- cells to undergo apoptosis in myelodysplastic marrows.
Mundle S; Venugopal P; Shetty V; Ali A; Chopra H; Handa H; Rose S; Mativi BY; Gregory SA; Preisler HD; Raza A
Int J Hematol; 1999 Apr; 69(3):152-9. PubMed ID: 10222652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]